$CLVS News Article - Clovis Oncology's Rubraca (R
Post# of 74549
(Total Views: 83)
Posted On: 03/31/2022 9:50:49 AM
$CLVS News Article - Clovis Oncology's Rubraca (Rucaparib) Significantly Improves Progression-Free Survival in First-line Maintenance Treatment in Women with Ovarian Cancer Regardless of Their Biomarker Status in Phase 3 ATHENA-MONO Trial https://marketwirenews.com/news-releases/clov...04836.html
(0)
(0)
My Twitter: WhyteStocks